Ebele Joan Ajagun

Ebele Joan Ajagun

Auto-generated profile, based on publicly available information

Ebele Joan Ajagun

National Biotechnology Development Agency (NABDA)

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2024
Verified
Book Chapter
Closed access
PDF file
EAEbele Joan Ajagun
Ebele Joan Ajagun
AAAbraham Olufemi Asuku
Abraham Olufemi Asuku
MAMaryam Tayo Ayinla
Maryam Tayo Ayinla
TATaoheed Adedeji Abdulsalam
Taoheed Adedeji Abdulsalam
AAAyodeji Johnson Ajibare
Ayodeji Johnson Ajibare
KGKaosara Oyinola Ganiyu
Kaosara Oyinola Ganiyu
Parkinson’s disease (PD) or Parkinsonism is an age-related progressive neurological disorder because of the deterioration of the nerve cells inside the substantia nigra, and it is characterized by three cardinal signs: rigidity, resting tremor, and bradykinesia. The major aim of therapy is to control the disorder’s signs and symptoms, delay the progression of the disease, and enhance the affected person’s quality of life (QoL). This can be achieved by the use of medication (drugs) and surgery. Pharmacotherapy of PD refers to utilizing drugs to replace, mimic, or potentiate the action of depleted endogenous brain’s dopamine and aims at delaying the progression of the disorder, reducing the drugs’ adverse effects, and improving the patient’s QoL. Drugs employed in the treatment of PD are broadly divided into two categories: dopaminergic system-acting drugs and cholinergic system-acting drugs. However, levodopa remains the first choice drug for the management of Parkinsonism to date. Despite the availability of drugs for the management of Parkinsonism, the progressive nature of the disorder has resulted in their failure to confer lasting therapeutic efficacy as the majority of the features of the disease become resistant to these drugs. Also, severe adverse effects with little or lack of enhancement in the patient’s QoL often accompany the use of multiple drug regimens, hence limiting the attainment of the overall goal of pharmacotherapy. <!----> <!----> <!----> <!---->

29 August 2024
Verified
Book Chapter
Closed access
PDF file
AAAbraham Olufemi Asuku
Abraham Olufemi Asuku
MAMaryam Tayo Ayinla
Maryam Tayo Ayinla
TOTobiloba S Olajide
Tobiloba S Olajide
EAEbele Joan Ajagun
Ebele Joan Ajagun
KGKaosara Oyinola Ganiyu
Kaosara Oyinola Ganiyu
TATaoheed Adedeji Abdulsalam
Taoheed Adedeji Abdulsalam
Parkinson’s disease (PD), also known as Parkinsonism, is a neurological condition that mostly, but not solely, impairs movement control. It is distinguished by an increased deterioration and loss of dopamine-producing neurons in the substantia nigra area of the brain. The exact aetiology of PD is complicated and multifaceted. It is considered to comprise a blend of genetic vulnerability and environmental variables that contribute to the development of the condition. Some of the important reasons include heredity, the pile-up of abnormal alpha-synuclein proteins in the brain and enteric nervous systems, heavy metal neurotoxicity, head trauma, and so on. Over the years, the diagnosis of PD has mostly hinged on the clinical triad of its movement-related symptoms: tremor, rigidity, and bradycardia. Though these symptoms are not prodromal of PD, they are often detected in the extremely severe phase of the illness when therapies and treatments are no longer highly effective. Therefore, this review focuses on the need for understanding the prodromal biomarkers associated with PD, such as non-motor biomarkers, biochemical biomarkers, and inflammatory biomarkers, as well as advances in neuroimaging biomarkers, in order to facilitate new diagnostic methods other than the normal motor symptoms to aid early diagnosis and responsive therapies and treatments of the disease. Some new discoveries, such as that of distinct neural networks and pathways of the illness, combination biomarkers, and salivary gland biopsy, are promising and could assist to quickly detect the condition. <!----> <!----> <!----> <!---->

7 August 2024 in South African Journal of Botany
Verified
Journal Article
Open access
MAMutiu Alabi
Mutiu Alabi
TATemidayo O. Adigun
Temidayo O. Adigun
EAEbele J. Ajagun
Ebele J. Ajagun
JAJanet F. Adeegbe
Janet F. Adeegbe
TITaiwo H. Ibrahim
Taiwo H. Ibrahim
Ram PrasadRam Prasad
Ram Prasad

25 October 2024
Verified
Book Chapter
Closed access
AAAbraham Olufemi Asuku
Abraham Olufemi Asuku
AAAyodeji Johnson Ajibare
Ayodeji Johnson Ajibare
EAEbele Joan Ajagun
Ebele Joan Ajagun
SBSaliu Salam Babatunde
Saliu Salam Babatunde
TOTobiloba S Olajide
Tobiloba S Olajide
OOOlawunmi Anthonia Odugbesan
Olawunmi Anthonia Odugbesan
This chapter discusses natural compounds recognized for their antiaging properties and describes the underlying mechanisms of action, providing a concise synopsis of studies on the efficacy of herbal extracts in antiaging products. The potential of certain herbal extracts, such as green tea, ginkgo, licorice, Aloe vera, and ginseng, in treating various signs of aging has been investigated in response to the growing demand for natural alternatives. Their mechanisms of action, which primarily target antioxidant defense, collagen production, and cellular repair, explain how they reduce oxidative stress, improve skin elasticity, and promote cellular rejuvenation. The chapter then discusses future trends and issues and proposes potential solutions.

28 December 2024
Verified
Book Chapter
Closed access
PDF file
AAAbraham Olufemi Asuku
Abraham Olufemi Asuku
TTTOHEEB OLALEKAN Toheeb
TOHEEB OLALEKAN Toheeb
EAEbele Joan Ajagun
Ebele Joan Ajagun
HSHammed A. Sangodipe
Hammed A. Sangodipe
WSWasiu Sanusi
Wasiu Sanusi
LJLukman Akanni Jayeoba
Lukman Akanni Jayeoba

28 December 2024
Verified
Book Chapter
Closed access
PDF file
EAEbele Joan Ajagun
Ebele Joan Ajagun
AAAbraham Olufemi Asuku
Abraham Olufemi Asuku
TTTOHEEB OLALEKAN Toheeb
TOHEEB OLALEKAN Toheeb
HSHammed A. Sangodipe
Hammed A. Sangodipe
WSWasiu Sanusi
Wasiu Sanusi
TATaoheed Adedeji Abdulsalam
Taoheed Adedeji Abdulsalam